Robert A. Gasser
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Robert A. Gasser has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Chansuda Wongsrichanalai
Department of Immunology, Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand
1 shared publication - Clinton K. Murray
San Antonio Military Medical Center
1 shared publication David Bell
Malaria, other Vector‐borne and Parasitic Diseases (MVP), World Health Organization Western Pacific Region (WHO/WPRO), Manila, The Philippines
1 shared publication
Latest Publications
- Open Access
- 30 September 2003
- Published by Wiley in Tropical Medicine & International Health
- Vol. 8 (10) , 876-883
Rapid diagnostic testing for malaria
Summary: Malaria rapid diagnostic devices (MRDD) have been developed with the hope that they would offer accurate, reliable, rapid, cheap and easily available alternatives to traditional methods of malaria diagnosis. The results from early malaria rapid diagnostic studies were quite promising, especially for detecting Plasmodium falciparum at densities of more than 100–500 parasites/μl. Despite the introduction of these devices over a decade ago, only a few target antigens have been introduced. Of greater concern, these devices have shown limitations in sensitivity, ability to differentiate species and robustness under field conditions in the tropics. Recent trials have revealed wide variability in sensitivity both within and between products. We review the recent trials assessing MRDD use for the diagnosis of P. falciparum and non‐P. falciparum infections in endemic and non‐endemic countries and describe the various aspects of these devices which need further improvement. High quality, accurate, rapid and affordable diagnostic tools are urgently needed now that new antimalarial regimens, characterized by higher cost and increased toxicity, have been introduced more widely in response to emerging multi‐drug resistance.
- 30 September 2003
- Published by Wiley in Tropical Medicine & International Health
- Vol. 8 (10) , 876-883
Open AccessRapid diagnostic testing for malaria
Summary: Malaria rapid diagnostic devices (MRDD) have been developed with the hope that they would offer accurate, reliable, rapid, cheap and easily available alternatives to traditional methods of malaria diagnosis. The results from early malaria rapid diagnostic studies were quite promising, especially for detecting Plasmodium falciparum at densities of more than 100–500 parasites/μl. Despite the introduction of these devices over a decade ago, only a few target antigens have been introduced. Of greater concern, these devices have shown limitations in sensitivity, ability to differentiate species and robustness under field conditions in the tropics. Recent trials have revealed wide variability in sensitivity both within and between products. We review the recent trials assessing MRDD use for the diagnosis of P. falciparum and non‐P. falciparum infections in endemic and non‐endemic countries and describe the various aspects of these devices which need further improvement. High quality, accurate, rapid and affordable diagnostic tools are urgently needed now that new antimalarial regimens, characterized by higher cost and increased toxicity, have been introduced more widely in response to emerging multi‐drug resistance.